252 results on '"Luikart H"'
Search Results
2. Cutting to the Bone: Impact of Redo Sternotomy on Outcome of Adult Heart Transplant
3. Updates from the International Consortium on Primary Graft Dysfunction: An Interim Report and Important Themes
4. Plasma Cell-Free DNA Chromatin Immunoprecipitation Distinguishes Acute Rejection Subtypes After Heart Transplantation
5. Impact of the 2018 UNOS Allocation Change on Severe Primary Graft Dysfunction: A Report from the International Consortium on PGD
6. Validation of a Machine Learning Primary Graft Dysfunction Risk Score in a Contemporary Heart Transplant Cohort: An Analysis of the International Consortium on PGD
7. Challenging the Conventional Wisdom of Apixaban Dose Adjustments in Heart Transplants on Posaconazole with and without Dialysis
8. Reasons for Donor Heart Offer Refusal Often Contradict Objective Cardiac Diagnostic Findings: Results from the Donor Heart Study
9. Mitigating Risk by Using the Primary Graft Dysfunction-Artificial Intelligence (PGD-AI) Calculator in a Contemporary Toronto Cohort: An Analysis from The International Consortium on PGD
10. Comparative Regional Analysis of Severe Primary Graft Dysfunction: Insights from Tthe International Consortium on PGD
11. Just a Number? Donor Age and (Lack of) Associated Reasons for Heart Offer Refusal in the Donor Heart Study
12. A Molecular Criteria for Antibody Mediated Rejection in Lung Transplant Recipients is Associated with an Increased Risk of the Composite Outcome of CLAD and Death
13. Donor “Left Ventricular Hypertrophy” is Often Transient and/or Spurious
14. Association of Donor-Derived Cell-Free DNA Levels with the Development of De Novo Donor-Specific Antibodies and Risk of Death in Lung Transplant Recipients
15. Dot Your I's and Check Your T's? Impact of Various T Cell Monitoring Methods on Heart Transplant Outcomes
16. (504) Correlation of Donor Electrocardiogram Abnormalities with Donor Echocardiograms and Angiograms: The Donor Heart Study
17. Prediction of Donor Heart Acceptance for Transplant: Results From the Donor Heart Study
18. (507) Leukotriene B4 Mediates Development of Cardiac Allograft Vasculopathy after Heart Transplantation
19. (271) Bye-Bye Biopsy? Comparing Short and Long-Term Outcomes after Adopting Early Non-Invasive Rejection Surveillance
20. Incidence and Predictors of Vasoplegia after Heart Transplantation: Results from the International PGD Consortium
21. Tixagevimab and Cilgavimab Reduced the Likelihood of Covid after Heart Transplant in the Age of Omicron
22. Restrictive Allograft Syndrome Patients Have Higher Cell-Free DNA Assessed Allograft Injury Prior to Diagnosis
23. 6 vs 12 Month CMV Prophylaxis in CMV-Mismatched Heart Transplants
24. Don't Take Another Piece of My Heart: Substantial Reduction in Biopsies with Initiation of Non-Invasive Rejection Surveillance at One Month Post-Transplant
25. Spontaneous Donor Hypothermia is Independently Associated with Increased Risk of Primary Graft Dysfunction After Heart Transplant
26. Are Two Better Than One? Survival, Rejection, Complications and Length of Stay with Multiorgan Transplants Compared to Heart Alone
27. Sensitization is Independently Associated with Increased Risk of Primary Graft Dysfunction After Heart Transplantation
28. Incidence, Predictors, and Reversibility of Left Ventricular Dysfunction After Brain Death: The Donor Heart Study
29. Keep Your Cool! One Year Outcomes with Use of a Hypothermic Preservation System Compared to Standard Storage with Ice During Heart Procurement
30. (447) - The ABCs of DSAs: Incidence, Class, Gene and Strength of Donor Specific Antibody Development in the First Year After Heart Transplant
31. (442) - Donor “Left Ventricular Hypertrophy” is Often Transient and/or Spurious
32. (1398) - Challenging the Conventional Wisdom of Apixaban Dose Adjustments in Heart Transplants on Posaconazole with and without Dialysis
33. (1233) - Cutting to the Bone: Impact of Redo Sternotomy on Outcome of Adult Heart Transplant
34. (770) - Comparative Regional Analysis of Severe Primary Graft Dysfunction: Insights from Tthe International Consortium on PGD
35. (768) - Mitigating Risk by Using the Primary Graft Dysfunction-Artificial Intelligence (PGD-AI) Calculator in a Contemporary Toronto Cohort: An Analysis from The International Consortium on PGD
36. (620) - Association of Donor-Derived Cell-Free DNA Levels with the Development of De Novo Donor-Specific Antibodies and Risk of Death in Lung Transplant Recipients
37. (340) - Plasma Cell-Free DNA Chromatin Immunoprecipitation Distinguishes Acute Rejection Subtypes After Heart Transplantation
38. (326) - Impact of the 2018 UNOS Allocation Change on Severe Primary Graft Dysfunction: A Report from the International Consortium on PGD
39. (285) - Sex Based Differences in Severe Primary Graft Dysfunction: An Analysis from the International Consortium on PGD
40. (196) - Dot Your I's and Check Your T's? Impact of Various T Cell Monitoring Methods on Heart Transplant Outcomes
41. (145) - Reasons for Donor Heart Offer Refusal Often Contradict Objective Cardiac Diagnostic Findings: Results from the Donor Heart Study
42. (141) - Young at Heart: Survival Among Septuagenarian Heart Transplant Recipient Has Decreased Over the Past Decade
43. (142) - Just a Number? Donor Age and (Lack of) Associated Reasons for Heart Offer Refusal in the Donor Heart Study
44. (124) - Validation of a Machine Learning Primary Graft Dysfunction Risk Score in a Contemporary Heart Transplant Cohort: An Analysis of the International Consortium on PGD
45. (122) - Updates from the International Consortium on Primary Graft Dysfunction: An Interim Report and Important Themes
46. (51) - A Molecular Criteria for Antibody Mediated Rejection in Lung Transplant Recipients is Associated with an Increased Risk of the Composite Outcome of CLAD and Death
47. (442) - Donor "Left Ventricular Hypertrophy" is Often Transient and/or Spurious.
48. Impact of AMR Treatment: Responders vs Non-Responders Characteristics
49. Very Temporary Mechanical Support Prior to Heart Transplant: Post-Transplant Outcomes as Status 1-2 versus 3-6 in the Setting of Short Wait Times
50. Racial Differences in Immunosuppression and Lung Transplant Outcomes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.